WallStreetZenWallStreetZen

NASDAQ: ARAV
Aravive Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ARAV

Based on 4 analysts offering 12 month price targets for Aravive Inc.
Min Forecast
$10.00+455.56%
Avg Forecast
$12.50+594.44%
Max Forecast
$18.00+900%

Should I buy or sell ARAV stock?

Based on 4 analysts offering ratings for Aravive Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARAV stock forecasts and price targets.

ARAV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
EF Hutton
Bottom 4%
4
Strong BuyReiterates$10.00+455.56%2023-05-26
HC Wainwright & Co.
Top 10%
91
BuyReiterates$12.00+566.67%2023-05-26
Cantor Fitzgerald
Bottom 3%
3
Strong BuyReiterates$18.00+900.00%2023-05-17
EF Hutton
Bottom 22%
22
Strong BuyInitiates Coverage On$10.00+455.56%2023-01-05

1 of 1

Forecast return on equity

Is ARAV forecast to generate an efficient return?

Forecast return on assets

Is ARAV forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

ARAV revenue growth forecast

How is ARAV forecast to perform vs Biotechnology companies and vs the US market?
Company
62.32%
Industry
39.96%
Market
8.44%
ARAV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARAV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARAV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARAV$1.80$12.50+594.44%Strong Buy
MNOV$2.19N/AN/A
OCGN$0.47$4.00+747.46%Strong Buy
CVM$2.43$13.00+434.98%Strong Buy
TALS$2.53$7.50+196.44%Buy
View Top Biotech Stocks

Aravive Stock Forecast FAQ

Is Aravive Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ARAV) stock is to Strong Buy ARAV stock.

Out of 4 analysts, 3 (75%) are recommending ARAV as a Strong Buy, 1 (25%) are recommending ARAV as a Buy, 0 (0%) are recommending ARAV as a Hold, 0 (0%) are recommending ARAV as a Sell, and 0 (0%) are recommending ARAV as a Strong Sell.

If you're new to stock investing, here's how to buy Aravive stock.

What is ARAV's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ARAV) forecast ROE is N/A, which is considered weak.

What is ARAV's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ARAV price target, the average ARAV price target is $12.50, with the highest ARAV stock price forecast at $18.00 and the lowest ARAV stock price forecast at $10.00.

On average, Wall Street analysts predict that Aravive's share price could reach $12.50 by May 26, 2024. The average Aravive stock price prediction forecasts a potential upside of 594.44% from the current ARAV share price of $1.80.

What is ARAV's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ARAV) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.